Clifford Chance Company Profile

12:48 EST 21st November 2017 | BioPortfolio


Our corporate group advises on some of the world's largest and most complex M&A transactions and equity offerings. We offer global transaction management capability with a full service English, US and civil law expertise. Our corporate practice is the largest of any law firm, with substantial resources in the key financial and business centres across Europe, the Americas and Asia.

Our clients include public and private corporations, investment banks and financial institutions, private equity providers, governments and international bodies. Our lawyers specialise in providing a seamless integrated service across our network of offices and across different areas of expertise.

Clifford Chance's position as one of the leading law firms in mergers & acquisitions is confirmed by the latest league tables. The tables, compiled by Thomson Financial Securities Data, rank advisers by total number and value of transactions. In 2001, we advised on 171 completed M&A transactions involving a European target company (2nd), with a combined value of US$97bn (3rd).


200 Aldersgate Street
New York
United Kingdom


Phone: +44 (0) 207 600 1000
Fax: +44 (0) 207 600 5555

News Articles [260 Associated News Articles listed on BioPortfolio]

Clifford Stocks from Calistoga discusses their acquisition by Gilead Pharmaceuticals

In this episode of PharmaTelevision News Review, Fintan Walton talks to Clifford Stocks, Chief Business Officer at Calistoga

Biohaven Brings Clifford Bechtold Aboard as Chief Operating Officer

Biohaven (NYSE: BHVN) has appointed Clifford Bechtold to serve as chief operating officer of the New Haven, CT, company. Bechtold most recently worked at Bristol-Myers Squibb (NYSE: BMY) as developmen...

Merck-Calls mit 130%-Chance bei Erreichen des Widerstandes

Merck-Calls mit 130%-Chance bei Erreichen des Widerstande Laut einer im BNP-Newsletter "dailyAktien" veröffentlichten Analyse besteht bei der Merck KGaA-Aktie (ISIN: DE0006599905) die Chance, ein ...

Pfizer's Mylotarg resurrected for new chance at US market

The cancer drug may get a second chance after being pulled from the market several years ago when it failed to gain full approval.

One IVF pregnancy raises chance of second time success

Women who miscarry during their first IVF cycle still have a higher chance of a live birth with subsequent treatment, compared with women who do not get pregnant after their first round...

Mum in her 30s discusses realities of life with a 75% chance of Alzheimer's

With a one in over 600 million chance of her parents both having the same rare, inherited gene, a young mum has spoken of the anguish of knowing she has a 75 percent risk of developing Alzheimer's in ...

CANVAS Proves CV Safety, Metabolic Value of Canagliflozin

British diabetes expert Clifford Bailey offers his take on the CANVAS data Medscape Diabetes & Endocrinology

RepliGen: Wieder auf dem richtigen Weg? Kommt das neue Allzeithoch?

Der Artikel dafür hatte den Titel: "RepliGen: Rekordumsatz im 2. Quartal bietet neue Trading-Chance!" Der genannte Einstiegskurs wurde noch nicht erreicht, aber es besteht die Chance, dass dieser T.....

Drugs and Medications [577 Associated Drugs and Medications listed on BioPortfolio]


Drug Facts Box - Back Label


Drug Facts Box - Back Label

Healthy accents [DZA Brands LLC]

Drug Facts Box - Back Label

Topcare [Topco Associates LLC]

Drug Facts Box - Back Label

Rite aid [Rite Aid Corporation]

Drug Facts Box - Back Label

PubMed Articles [87 Associated PubMed Articles listed on BioPortfolio]

Application of a Resource Theory for Magic States to Fault-Tolerant Quantum Computing.

Motivated by their necessity for most fault-tolerant quantum computation schemes, we formulate a resource theory for magic states. First, we show that robustness of magic is a well-behaved magic monot...

Healthy preconception nutrition and lifestyle using personalized mobile health coaching is associated with enhanced pregnancy chance.

Periconceptional nutrition and lifestyle are essential in pathogenesis and prevention of most reproductive failures, pregnancy outcome and future health. We aimed to investigate whether personalized m...

Quality of information about success rates provided on assisted reproductive technology clinic websites in Australia and New Zealand.

Many factors influence the chance of having a baby with assisted reproductive technologies (ART). A 2016 Australian Competition and Consumer Commission (ACCC) investigation concluded that ART clinics ...

Metachronous Bilateral Hemothorax Due to Reverse Chance Type Thoracic Fracture.

Metachronous bilateral hemothorax due to reverse Chance type thoracic fracture is very rare. In this case, we experienced a case of metachronous bilateral hemothorax, triggered by a thoracic fracture ...

An interval chance-constrained fuzzy modeling approach for supporting land-use planning and eco-environment planning at a watershed level.

An interval chance-constrained fuzzy land-use allocation (ICCF-LUA) model is proposed in this study to support solving land resource management problem associated with various environmental and ecolog...

Clinical Trials [432 Associated Clinical Trials listed on BioPortfolio]

Food Incentives for TB Treatment Compliance in East Timor (FITTCET)

This study will examine whether food is a cost-effective method for improving treatment compliance for TB patients in Timor Leste. Our hypothesis is that the provision of locally available...

The Long QT Syndrome in Pregnancy

Long QT Syndrome (LQTS) is a disease of young adults and can affect women of child bearing age. Suffers of LQTS are at risk of ventricular dysrhythmias including torsades de pointes and ve...

Adalat XL vs Diltiazem on Proteinuria and Blood Pressure in Hypertensive Diabetic Patients

The study consists of a 12 week run-in period when all subjects are stabilized on a single dose of Avalide (300 mg/12.5 mg or 300mg/25mg dose) per day. After this 12 week run-in ends, subj...

Tailoring Treatment for B Cell Non-hodgkin's Lymphoma Based on PET Scan Results Mid Treatment

The purpose of this study is to assess whether patients who are likely to fail R-CHOP, as predicted by a mid-treatment PET scan, can have an improved outcome if switched to a standard salv...

Dyskinesia in Parkinson's Disease (Study P04501AM3)(COMPLETED)

The purpose of the study is to assess the efficacy and safety of a range of doses of SCH 420814 when used together with a stable dose of L-dopa/dopa decarboxylase inhibitor to treat Parkin...

Companies [43 Associated Companies listed on BioPortfolio]

Clifford Chance

CorporateOur corporate group advises on some of the world's largest and most complex M&A transactions and equity offerings. We offer global transaction management capability with a full service Englis...

SDS Medical

SDS Medical is the vision of two healthcare entrepreneurs with over 30 years of experience in their respective fields – Allan Thomas and Phillip Clifford. Allan Thomas, CEO a...


ADERANT, headquartered in Atlanta, GA, is a leading provider of integrated business management software for law firms and other services organizations. The global company offers a...

Karmanos Cancer Institute

When cancer strikes, your first chance is your best chance. And your best chance is at the Barbara Ann Karmanos Cancer Institute. Backed by state-of-the-science cancer research conducted right here in...

A Second Chance, Inc.

More Information about "Clifford Chance" on BioPortfolio

We have published hundreds of Clifford Chance news stories on BioPortfolio along with dozens of Clifford Chance Clinical Trials and PubMed Articles about Clifford Chance for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clifford Chance Companies in our database. You can also find out about relevant Clifford Chance Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record